Modis Therapeutics

Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.

Launch date

2016

Market cap

Enterprise valuation

$250m (Public information from Aug 2019)

Oakland California (HQ)

Date	Investors	Amount	Round
-	Eight Roads Ventures	N/A	-
Oct 2018	OrbiMed F-Prime	$30.0m	Series A
Aug 2019	Zogenix	$250m Valuation: $250m	Acquisition
Total Funding		$30.0m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Modis Therapeutics